Navigation Links
3 Common Drugs Trigger Most ER Visits by Seniors
Date:12/4/2007

Warfarin, insulin and digoxin account for a third of drug-related ER trips, study says

TUESDAY, Dec. 4 (HealthDay News) -- Side effects from just three drugs are responsible for a full third of all U.S. emergency room visits by senior citizens who had adverse reactions to medications, a new study found.

In 2004 and 2005, the blood thinner warfarin, the diabetes drug insulin and the heart drug digoxin caused about 58,000 emergency room visits a year in those 65 and older, the researchers found.

The major problem is that it's hard to determine the correct dose for each drug, said study lead author Dr. Daniel Budnitz, a medical officer with the U.S. Centers for Disease Control and Prevention (CDC).

"It's challenging," he said, "and it takes work between the patient and physician to get the dose just right."

Budnitz and his colleagues undertook the study to determine the danger posed to senor citizens by a long list of drugs that have been deemed "potentially inappropriate" for use in the elderly.

The researchers looked at several surveys of emergency room visits from 2004 and 2005. The study findings are published in the Dec. 4 issue of the Annals of Internal Medicine.

Forty-one drugs are on the list -- called the BEERS criteria -- of medications considered inappropriate for the elderly. But they accounted for just 3.6 percent of a total of about 177,000 annual emergency room visits.

Warfarin (also known as Coumadin), insulin and digoxin (which has a number of trade names) posed many more problems. (Digoxin is also on the list of potentially inappropriate drugs for the elderly, but it's only listed as a potential problem if taken in certain situations.)

All three medications are well-known, commonly used drugs and all can create problems in some cases.

Warfarin, often prescribed to heart patients, prevents blood clots by thinning the blood, but can cause excessive bleeding if the blood becomes too thin. Insulin treats diabetes but can sometimes cause blood sugar levels to drop to dangerous levels. And digoxin, a long-used drug, can cause a variety of problems from nausea to erratic heartbeats.

In some cases, there aren't good alternatives to these three drugs, although some doctors consider digoxin to have outlived its usefulness, the study authors noted.

Doctors can monitor the levels of all three drugs with blood tests, Budnitz said. Simple finger-prick blood tests allow testing of blood sugar levels, and similar tests measuring clotting ability are now available in some clinics for people taking warfarin, he said.

The study results are "a reminder that doctors and patients need to work on doing the best job we can managing these medicines," Budnitz said. "The answer isn't to take away medications."

Dr. Knight Steel, head of geriatric medicine at Hackensack University Medical Center in New Jersey, said the study results aren't really surprising. Doctors have long known the risks of the three drugs in question, he said, adding that the research doesn't provide any new information.

More information

To learn more about the health risks that drugs can pose to the elderly, visit Duke University Health System.



SOURCES: Daniel Budnitz, M.D., medical officer, U.S. Centers for Disease Control and Prevention, Atlanta; Knight Steel, M.D., chief of geriatrics, Hackensack University Medical Center, New Jersey; Dec. 4, 2007, Annals of Internal Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UK junior doctors gaining less experience of common procedures
2. New insights into common knee injuries
3. High and mighty: first common height gene identified by researchers behind obesity gene finding
4. Figure Skater Peggy Fleming, HealthSaver Says: Take Pains For Back Strains, 2nd Most Common Doctor Complaint
5. Exelixis Commences Public Offering of Common Stock
6. Common misdiagnosis: most women believe they have a yeast infection when they dont
7. Business Executives Discuss National Health Care Reform at Conference Sponsored by The Century Foundation, with Support from The Commonwealth Fund, and AARP
8. New Expert Report Dispels Common Myths About Aspartame
9. Common Foot Myths Trip Us Up
10. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
11. Allergy-Induced Asthma More Common in Affluent Countries
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
3 Common Drugs Trigger Most ER Visits by Seniors
(Date:2/8/2016)... ... ... FileHold's document management software has been implemented by DocuSyst ... for FileHold software that is pay per user subscription-based and also does on-premise ... web services API. DocuSyst also advises clients on fully functioning back up technologies ...
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... ... showing greater than 50% lower incidence rate of type 2 diabetes in the ... averages. ”It is time to make a change in public health,” states Carole ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com recently ... in Mole removal products. , Moles are derived from a cluster of melanin when ... all the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
(Date:2/8/2016)... NV (PRWEB) , ... February 08, 2016 , ... Guruji ... February 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... true happiness. Mahendra Trivedi is known by over 250,000 people from over 40 ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by the ... dental technicians to be certified or obtain continuing education. To increase patient awareness ... In Your Mouth?” campaign to inform dentists and patients about the possible lack ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology: